Insider · CIK 0001135041
Nancy T Chang
Files at WTI (W&T OFFSHORE INC), GRTX (Galera Therapeutics, Inc.), IMMX (Immix Biopharma, Inc.). First filing Jan 2, 2025, latest Jan 2, 2025.
Nancy T Chang files SEC Form 4 as director and 10% owner at GRTX (Galera Therapeutics, Inc.), and also at WTI (W&T OFFSHORE INC), IMMX (Immix Biopharma, Inc.). Since Jan 2, 2025, Nancy T Chang has reported 1 open-market buy worth $500k and 0 open-market sells worth $0, the latest filed on Jan 2, 2025.
A track record needs three past buys with six months of prices behind them; Nancy T Chang has 0, so none is measured yet.
The newest scored trade: bought $500k of GRTX on Dec 30, 2024, filed Jan 2, 2025, scored 41 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | GRTXbuy Galera Therapeutics, Inc. | $500k 7,644,932 shares | - | - |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | WTI W&T OFFSHORE INC | MOption exercise Common Stock | +103,448 | - | - | 216,100 | Jun 5, 2026 |
| Jun 3, 2026 | WTI W&T OFFSHORE INC | AGrant or award Restricted Stock Unitsderivative | +35,972 | $0.00 | $0 | 35,972 | Jun 5, 2026 |
| Jun 3, 2026 | WTI W&T OFFSHORE INC | MOption exercise Restricted Stock Unitsderivative | -103,448 | $0.00 | $0 | 0 | Jun 5, 2026 |
| May 22, 2026 | IMMX Immix Biopharma, Inc. | AGrant or award Common Stock | +6,250 | $0.00 | $0 | 428,190 | May 29, 2026 |
| May 22, 2026 | IMMX Immix Biopharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +12,500 | $0.00 | $0 | 12,500 | May 29, 2026 |
| Apr 7, 2026 | GRTX Galera Therapeutics, Inc. | CConversion Common Stock | +1,180,611 | - | - | 8,825,543 | Apr 9, 2026 |
| Apr 7, 2026 | GRTX Galera Therapeutics, Inc. | CConversion Series B Preferred Stockderivative | -1,181 | $0.00 | $0 | 661 | Apr 9, 2026 |
| Nov 21, 2025 | IMMX Immix Biopharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +39,643 | $0.00 | $0 | 39,643 | Dec 11, 2025 |
| Jun 3, 2025 | WTI W&T OFFSHORE INC | MOption exercise Common Stock | +73,892 | - | - | 112,652 | Jun 5, 2025 |
| Jun 3, 2025 | WTI W&T OFFSHORE INC | AGrant or award Restricted Stock Unitsderivative | +103,448 | $0.00 | $0 | 103,448 | Jun 5, 2025 |
| Jun 3, 2025 | WTI W&T OFFSHORE INC | MOption exercise Restricted Stock Unitsderivative | -73,892 | $0.00 | $0 | 0 | Jun 5, 2025 |
| Feb 24, 2025 | GRTX Galera Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +96,000 | $0.00 | $0 | 96,000 | Feb 26, 2025 |
| Dec 30, 2024 | GRTX Galera Therapeutics, Inc. | POpen-market purchase Common Stock | +7,644,932 | $0.07 | $500k | 7,644,932 | Jan 2, 2025 |
| Dec 30, 2024 | GRTX Galera Therapeutics, Inc. | AGrant or award Series B Preferred Stockderivative | +1,842 | $0.00 | $0 | 1,842 | Jan 2, 2025 |
Questions about Nancy T Chang
Answered from the filings on this page, as of the latest one.
Is Nancy T Chang buying or selling?
Not in the last 12 months. Nancy T Chang's latest open-market trade on SEC Form 4 was bought $500k of GRTX on Dec 30, 2024.
How did Nancy T Chang's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Nancy T Chang has 0.
Where does Nancy T Chang file Form 4?
Nancy T Chang has filed Form 4 at GRTX (Galera Therapeutics, Inc.); WTI (W&T OFFSHORE INC); IMMX (Immix Biopharma, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.